Human Papillomavirus (HPV) ACIP Vaccine Recommendations
Advisory Committee on Immunization Practices (ACIP)
On This Page
Published in Morbidity and Mortality Weekly Report (MMWR)
The Advisory Committee on Immunization Practices (ACIP)provides advice and guidance to the Director of the CDC regarding use of vaccines and related agents for control of vaccine-preventable diseases in the civilian population of the United States. Recommendations made by the ACIP are reviewed by the CDC Director and, if adopted, are published as official CDC/HHS recommendations in the Morbidity and Mortality Weekly Report (MMWR).
9-valent HPV Vaccine
Additional guidance [4 pages] for providers regarding 9-vHPV vaccine use among persons who previously received 2vHPV or 4vHPV vaccine.
CURRENT HPV Vaccine Recommendations
- Meites E, Szilagyi PG, Chesson HW, Unger ER, Romero JR, Markowitz LE. Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices MMWR. 2019;68(32);698-702.
Print version [5 pages] - Meites E, Kempe A, Markowitz LE. Use of a 2-Dose Schedule for Human Papillomavirus Vaccination — Updated Recommendations of the Advisory Committee on Immunization Practices MMWR. 2016;65(49);1405-8.
Print version [4 pages] - Petrosky E, Bocchini JA, Hariri S, Chesson H, Curtis CR, Saraiya M, et al. Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory Committee on Immunization Practices MMWR. 2015;64(11);300-304.
Print version [5 pages] - MMWR, August 29, 2014, Vo1 63, #RR05
Human Papillomavirus Vaccination: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Print version [36 pages] - See also:
.png)
No hay comentarios:
Publicar un comentario